Interested in learning more about Burns & Levinson? Contact us today. We welcome all opportunities to explore how we can get things done for you and your business.
Burns & Levinson congratulates their client, Harvard Bioscience, Inc. for being ranked the number one biotech company in Massachusetts in the 2011 Boston Globe 100, the Boston Globe's annual survey of the best-performing public companies headquartered in Massachusetts. Harvard Bioscience has also been ranked number 10 out of all 100 companies in the survey.
Harvard Bioscience is a global developer, manufacturer and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used to advance life science research and regenerative medicine at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. For first time in history, a patient has been given a new trachea made from a synthetic scaffold seeded with his own stem cells as a result of Harvard Bioscience technology. Read more about this remarkable achievement.
Josef Volman, Co-Chair of the Business Law Group at Burns & Levinson, lauded the efforts of the company: "We applaud Harvard Bioscience's inclusion in such a prestigious list and are proud to partner with them as they continue to influence the life science sector."
David Green, President, commented: "We are thrilled that the Boston Globe has recognized us as the number one biotech company in Massachusetts. This recognition is a consequence of our strong track record of growth and profitability of our core life science research tools business, even during the Great Recession, our exciting growth opportunity in regenerative medicine and the exceptional commitment of our employees around the globe."